Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Ziccum AB will be intensifying its partnering and networking dialogues at a series of leading pharma industry events throughout Europe this year. CEO Ann Gidner: “As we strengthen our connections with colleagues throughout the industry, we remain confident in the unique advantages that ambient drying and thermostable vaccines represent. It’s going to be an exciting season.”
CEO Ann Gidner and Chairman Fredrik Sjövall will attend Nordic Life Sciences Days in Malmö, 28 – 29 September, and Bio-Europe, the largest industry event for biopharma professionals in Europe, in Leipzig on 23 – 26 October.
The company’s CEO together with Scientific Director Fabrice Rose will attend the New Updates in Drug Formulation & Bioavailability conference in Copenhagen on September 6, and the 23rd World Vaccine Congress Europe conference in Barcelona October 11 – 14.
Ziccum CEO Ann Gidner: “Since my appointment in May we have constantly emphasized our commitment to building new strategic dialogues and relationships within the industry. Our unique ambient drying technology for vaccines and biologics is an enormously valuable technology. Together with our Chairman and Scientific Director I look forward to sharing our science and offering at these important industry events.”
BOOK A MEETING ahead of the events with CEO Ann Gidner, Chairman Fredrik Sjövall or Scientific Director Fabrice Rose here:
Ann Gidner CEO - Mobile: +46 722 140 141
e-mail: gidner@ziccum.com
Fredrik Sjövall, Chairman - Mobile: +46 706 45 0875
e-mail: sjovall@ziccum.com
Fabrice Rose, Scientific Director: +46 709 802 520
e-mail: rose@ziccum.com